Những phát hiện lâm sàng liên quan đến tỷ lệ tử vong trong các nhiễm trùng do vi khuẩn mycobacteria không gây lao: bệnh nhân mắc phức hợp Mycobacterium avium có khả năng sống sót tốt hơn so với bệnh nhân mắc các loại mycobacteria khác

Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, Sørensen HT, Lescure F-X, Thomsen RW (2010) Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 181:514–521 Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL (2009) Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 49:e124–e129 Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB (2013) Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998–2010. Emerg Infect Dis 19:1889–1891 Simons S, van Ingen J, Hsueh P-R, Van Hung N, Dekhuijzen PNR, Boeree MJ, van Soolingen D (2011) Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia. Emerg Infect Dis 17:343–349 de Mello KGC, Mello FCQ, Borga L, Rolla V, Duarte RS, Sampaio EP, Holland SM, Prevots DR, Dalcolmo MP (2013) Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993–2011. Emerg Infect Dis 19:393–399 Hoefsloot W, van Ingen J, Andrejak C, Ängeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, Chimara E, Churchyard G, Cias R, Daza R, Daley CL, Dekhuijzen PN, Domingo D, Drobniewski F, Esteban J, Fauville-Dufaux M, Folkvardsen DB, Gibbons N, Gómez-Mampaso E, Gonzalez R, Hoffmann H, Hsueh PR, Indra A, Jagielski T, Jamieson F, Jankovic M, Jong E, Keane J, Koh WJ, Lange B, Leao S, Macedo R, Mannsåker T, Marras TK, Maugein J, Milburn HJ, Mlinkó T, Morcillo N, Morimoto K, Papaventsis D, Palenque E, Paez-Peña M, Piersimoni C, Polanová M, Rastogi N, Richter E, Ruiz-Serrano MJ, Silva A, da Silva MP, Simsek H, van Soolingen D, Szabó N, Thomson R, Tórtola Fernandez T, Tortoli E, Totten SE, Tyrrell G, Vasankari T, Villar M, Walkiewicz R, Winthrop KL, Wagner D; Nontuberculous Mycobacteria Network European Trials Group (2013) The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 42:1604–1613 Kotilainen H, Valtonen V, Tukiainen P, Poussa T, Eskola J, Järvinen A (2011) Clinical symptoms and survival in non-smoking and smoking HIV-negative patients with non-tuberculous mycobacterial isolation. Scand J Infect Dis 43:188–196 Hoefsloot W, van Ingen J, de Lange WCM, Dekhuijzen PNR, Boeree MJ, van Soolingen D (2009) Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J 34:926–931 Petrini B (2006) Non-tuberculous mycobacterial infections. Scand J Infect Dis 38:246–255 Kotilainen H, Valtonen V, Tukiainen P, Poussa T, Eskola J, Järvinen A (2013) Prognostic value of American Thoracic Society criteria for non-tuberculous mycobacterial disease: a retrospective analysis of 120 cases with four years of follow-up. Scand J Infect Dis 45:194–202 Ito Y, Hirai T, Fujita K, Maekawa K, Niimi A, Ichiyama S, Mishima M (2015) Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan. J Infect Chemother 21:352–356 Chu H, Zhao L, Xiao H, Zhang Z, Zhang J, Gui T, Gong S, Xu L, Sun X (2014) Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis. Arch Med Sci 10:661–668 Russell CD, Claxton P, Doig C, Seagar A-L, Rayner A, Laurenson IF (2014) Non-tuberculous mycobacteria: a retrospective review of Scottish isolates from 2000 to 2010. Thorax 69:593–595 Yeh JJ, Wang YC, Sung FC, Chou CY, Kao CH (2014) Nontuberculosis mycobacterium disease is a risk factor for chronic obstructive pulmonary disease: a nationwide cohort study. Lung 192:403–411 Mirsaeidi M, Machado RF, Garcia JGN, Schraufnagel DE (2014) Nontuberculous mycobacterial disease mortality in the United States, 1999–2010: a population-based comparative study. PLoS One 9:e91879 Yeh J-J, Wang Y-C, Lin C-L, Chou CY-T, Yeh T-C, Wu B-T, Sung F-C, Kao C-H (2014) Nontuberculous mycobacterial infection is associated with increased respiratory failure: a nationwide cohort study. PLoS One 9:e99260 Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416 Piersimoni C, Scarparo C (2008) Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 8:323–334 El Helou G, Viola GM, Hachem R, Han XY, Raad II (2013) Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 13:166–174 Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y (2012) Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 185:575–583 Lee MR, Yang CY, Shu CC, Lin CK, Wen YF, Lee SW, Ko JC, Wang JY, Lee LN, Yu CJ (2015) Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination. Clin Microbiol Infect 21:250.e1–250.e7 Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, Lin J, Jolley C, Sorbara L, Raffeld M, Hill S, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool R, Hilligoss DM, Garofalo M, Fitzgerald A, Anaya-O’Brien S, Darnell D, DeCastro R, Menning HM, Ricklefs SM, Porcella SF, Olivier KN, Moss J, Holland SM (2008) Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 78:1066–1074 Varadi RG, Marras TK (2009) Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review. Int J Tuberc Lung Dis 13:1210–1218 Arend SM, Cerdá de Palou E, de Haas P, Janssen R, Hoeve MA, Verhard EM, Ottenhoff THM, van Soolingen D, van Dissel JT (2004) Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect. Clin Microbiol Infect 10:738–748 Corbett EL, Churchyard GJ, Clayton T, Herselman P, Williams B, Hayes R, Mulder D, De Cock KM (1999) Risk factors for pulmonary mycobacterial disease in South African gold miners. A case–control study. Am J Respir Crit Care Med 159:94–99 Kotilainen H, Lokki M-L, Paakkanen R, Seppänen M, Tukiainen P, Meri S, Poussa T, Eskola J, Valtonen V, Järvinen A (2014) Complement C4 deficiency—a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients. PLoS One 9:e91450 McCabe WR, Jackson GG (1962) Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 110:847–855 Gommans EPAT, Even P, Linssen CFM, van Dessel H, van Haren E, de Vries GJ, Dingemans AMC, Kotz D, Rohde GGU (2015) Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study. Respir Med 109:137–145 Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW (2013) Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 68:256–262 Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED (2013) Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med 187:197–205 Taiwo B, Glassroth J (2010) Nontuberculous mycobacterial lung diseases. Infect Dis Clin North Am 24:769–789 Mirsaeidi M, Hadid W, Ericsoussi B, Rodgers D, Sadikot RT (2013) Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis 17:e1000–e1004 Chan ED, Iseman MD (2010) Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gend Med 7:5–18 Lee M-R, Yang C-Y, Chang K-P, Keng L-T, Yen DH-T, Wang J-Y, Wu H-D, Lee L-N, Yu C-J (2013) Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLoS One 8:e58214 Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, Fabian K, Ullmann AJ, Wulffraat N, Ljungman P, Alessandrino EP, Pretnar J, Gmür J, Varela R, Vitek A, Sica S, Rovira M; European Blood and Marrow Transplant Group Infectious Diseases Working Party (2004) Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis 38:1229–1236 Knoll BM, Kappagoda S, Gill RR, Goldberg HJ, Boyle K, Baden LR, Fuhlbrigge AL, Marty FM (2012) Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis 14:452–460 Henriques B, Hoffner SE, Petrini B, Juhlin I, Wåhlén P, Källenius G (1994) Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis 18:596–600 Henry MT, Inamdar L, O’Riordain D, Schweiger M, Watson JP (2004) Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 23:741–746